Cargando…
Early p53 mutations in nondysplastic Barrett's tissue detected by the restriction site mutation (RSM) methodology
Barrett's oesophagus is a premalignant condition whose incidence is rising dramatically. Molecular markers are urgently needed to identify Barrett's patients at the highest risk of cancer progression. To this end, we have used a rapid molecular technique, restriction site mutation (RSM), t...
Autores principales: | Jenkins, G J S, Doak, S H, Griffiths, A P, Tofazzal, N, Shah, V, Baxter, J N, Parry, J M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747568/ https://www.ncbi.nlm.nih.gov/pubmed/12698195 http://dx.doi.org/10.1038/sj.bjc.6600891 |
Ejemplares similares
-
Management of nondysplastic Barrett’s esophagus: When to survey? When
to ablate?
por: Puthenpura, Max M., et al.
Publicado: (2022) -
Incidence of Dysplasia in Obese vs Nonobese Patients With Nondysplastic Barrett Esophagus
por: Monardo, Ann, et al.
Publicado: (2019) -
Whole Genome Methylation Analysis of Nondysplastic Barrett Esophagus that Progresses to Invasive Cancer
por: Dilworth, Mark P., et al.
Publicado: (2019) -
The incidence of esophageal cancer and dysplasia in a Chinese population with nondysplastic Barrett's esophagus
por: Lee, Shou‐Wu, et al.
Publicado: (2018) -
Detection of p53 mutations in precancerous gastric tissue
por: Morgan, C, et al.
Publicado: (2003)